Detalles de la búsqueda
1.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38612799
2.
Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.
Oncologist
; 28(6): e391-e396, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37014824
3.
ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data.
Oncologist
; 27(1): e76-e84, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35305096
4.
Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer: A real-world evidence.
Int J Cancer
; 148(5): 1183-1191, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32875571
5.
The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Oncology
; 99(9): 555-561, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34247166
6.
Novel and Promising Systemic Treatment Approaches in Mesothelioma.
Curr Treat Options Oncol
; 22(10): 89, 2021 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34424409
7.
Rising Incidence of Lung Cancer in Arab Females, Jewish Females, and Arab Males from 1990 to 2014 in Israel.
Isr Med Assoc J
; 22(12): 788-793, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33381954
8.
Stereotactic Radiosurgery for Brain Metastases in Small Cell Lung Cancer: The Davidoff Cancer Center Experience.
Isr Med Assoc J
; 22(1): 22-26, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31927801
9.
Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndrome.
J Thromb Thrombolysis
; 47(1): 121-128, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30255420
10.
Circulating Tumor DNA T790M Testing as a Predictor of Osimertinib Efficacy in Epidermal Growth Factor Receptor Mutant Non-small Cell Lung Cancer: A Single Center Experience.
Isr Med Assoc J
; 21(6): 394-398, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31280508
11.
[THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER].
Harefuah
; 156(11): 686-691, 2017 11.
Artículo
en Hebreo
| MEDLINE | ID: mdl-29198084
12.
BRCA mutations detected by tumour next-generation sequencing in non-small cell lung cancer: impact on response to therapy and disease course.
Transl Lung Cancer Res
; 12(5): 1011-1022, 2023 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37323181
13.
Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy.
Biomedicines
; 11(6)2023 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37371825
14.
Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature.
Thorac Cancer
; 14(17): 1589-1596, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37095004
15.
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study.
Int J Radiat Oncol Biol Phys
; 117(1): 105-114, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36925073
16.
The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2nd/3rd-Generation ALK Tyrosine Kinase Inhibitors (TKIs).
Front Oncol
; 12: 874712, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35646707
17.
FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC).
J Clin Med
; 11(9)2022 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35566609
18.
dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50.
Clin Lung Cancer
; 23(2): 122-134, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35034862
19.
Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer.
Front Oncol
; 12: 1010311, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203432
20.
Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study.
Neurooncol Adv
; 4(1): vdab188, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35156036